Pre-clinical screening of drugs using the mdx mouse

[1]  E. Hoffman,et al.  Recruitment of mast cells to muscle after mild damage , 1996, Journal of the Neurological Sciences.

[2]  T. Vary,et al.  Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis. , 1995, The American journal of physiology.

[3]  M. S. Hudecki,et al.  Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80. , 1994, Research communications in chemical pathology and pharmacology.

[4]  Cecil B. Day,et al.  Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy , 1994, Annals of neurology.

[5]  E. Hoffman,et al.  A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice , 1994, Journal of the Neurological Sciences.

[6]  A. Pestronk,et al.  Duchenne dystrophy , 1993, Neurology.

[7]  T. Byrnes,et al.  Strength and endurance in the therapeutic evaluation of prednisolone-treated MDX mice. , 1993, Research communications in chemical pathology and pharmacology.

[8]  P. Mcneil,et al.  Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. , 1992, The American journal of pathology.

[9]  V. Dubowitz.  Prednisone in Duchenne dystrophy , 1991, Neuromuscular Disorders.

[10]  A. Pestronk,et al.  A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. , 1991, Archives of neurology.

[11]  R. Edwards,et al.  Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse. , 1991, Clinical science.

[12]  A. Pestronk,et al.  Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. , 1991, Archives of neurology.

[13]  T. Helliwell,et al.  Mast cells in neuromuscular diseases , 1990, Journal of the Neurological Sciences.

[14]  M. S. Hudecki,et al.  Mdx mouse as therapeutic model system: development and implementation of phenotypic monitoring. , 1990, Advances in experimental medicine and biology.

[15]  E A Barnard,et al.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.

[16]  J. Miller,et al.  Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.

[17]  B. Cooper.  Animal models of Duchenne and Becker muscular dystrophy. , 1989, British medical bulletin.

[18]  T. Partridge,et al.  THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION , 1988, Neuropathology and applied neurobiology.

[19]  T. Tsukahara,et al.  Negative immunostaining of Duchenne muscular dystrophy(DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. , 1988 .

[20]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[21]  J. Miller,et al.  Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. , 1987, Archives of neurology.

[22]  R. Kuncl,et al.  Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. , 1987, Archives of neurology.

[23]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[24]  V. Dubowitz,et al.  A role for collagen in the pathogenesis of muscular dystrophy? , 1980, Nature.

[25]  B. Mokri,et al.  Duchenne dystrophy , 1975, Neurology.

[26]  K. Toyka,et al.  PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY , 1974, The Lancet.

[27]  V. Dubowitz,et al.  Muscle biopsy: A modern approach , 1973 .

[28]  C. Pearson,et al.  Regeneration of human muscle. A morphologic and histochemical study of normal and dystrophic muscle after injury. , 1972, Laboratory investigation; a journal of technical methods and pathology.

[29]  Gerardo Cazzato.  Considerations about a possible role played by connective tissue proliferation and vascular disturbances in the pathogenesis of progressive muscular dystrophy. , 1968, European neurology.

[30]  Feste Nv.  Liberation of patients. , 1966 .

[31]  G. Bourne,et al.  Human Muscular Dystrophy as an Aberration of the Connective Tissue , 1959, Nature.